RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Raises Target Price to $62
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
QuidelOrtho Raised to Neutral From Sell by UBS
RBC Lifts Price Target on QuidelOrtho to $62 From $61, Keeps Outperform Rating
QuidelOrtho Analyst Ratings
Craig-Hallum Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $57
QuidelOrtho Price Target Maintained With a $61.00/Share by RBC Capital
QuidelOrtho Analyst Ratings
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $61
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
QuidelOrtho Price Target Maintained With a $61.00/Share by RBC Capital
QuidelOrtho Analyst Ratings
Craig-Hallum Maintains QuidelOrtho(QDEL.US) With Hold Rating, Announces Target Price $40
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $61
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
Craig-Hallum Maintains QuidelOrtho(QDEL.US) With Hold Rating
Craig-Hallum Reaffirms Their Hold Rating on QuidelOrtho (QDEL)
RBC Cuts Price Target on QuidelOrtho to $61 From $68, Keeps Outperform Rating
Royal Bank of Canada: Maintaining the QuidelOrtho (QDEL.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $81.00 to $68.00.
QuidelOrtho Analyst Ratings